`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________
`
`APOTEX INC., APOTEX CORP., APOTEX PHARMACEUTICALS
`HOLDINGS INC., and APOTEX HOLDINGS, INC.,
`Petitioners,
`
`v.
`
`OSI PHARMACEUTICALS, INC.,
`Patent Owner.
`________________
`
`U.S. Patent No. 6,900,221
`Issue Date: May 31, 2005
`Title of Patent: Stable Polymorph on N-(3-ethylphenyl)-6,7-bis(2methoxyethoxy)-
`4-quinazolinamine hydrochloride, Methods of Production,
`and Pharmaceutical uses thereof
`________________
`
`Case No.: IPR2016-01284
`________________
`
`PETITIONERS’ UPDATED MANDTAORY NOTICES
`
`
`
`
`
`
`
`
`
`
`
`LEGAL\31501518\1
`
`
`
`IPR2016-01284
`U.S. Patent No. 6,900,221
`PETITIONERS’ UPDATED MANDATORY NOTICE
`
`
`MANDATORY NOTICES (37 C.F.R. § 42.8(a)(1))
`Pursuant to 37 C.F.R. § 42.8, Petitioners Apotex Inc., Apotex Corp., Apotex
`
`Pharmaceuticals Holdings Inc., and Apotex Holdings, Inc, respectfully submits the
`
`following updated Mandatory Notices.
`
`
`
`I.
`Real Party-In-Interest (37 C.F.R. § 42.8(b)(1))
`Apotex Inc., Apotex Corp., Apotex Pharmaceuticals Holdings Inc., and
`
`Apotex Holdings, Inc. are the real parties-in-interest for Petitioners.
`
`Apotex Inc. is an Ontario corporation organized under Canadian laws, and is
`
`wholly owned by Apotex Pharmaceuticals Holdings Inc., which itself is wholly
`
`owned by Apotex Holdings, Inc. Both Apotex Pharmaceuticals Holdings Inc. and
`
`Apotex Holdings, Inc. are Ontario corporations. Apotex Corp. is a Delaware
`
`corporation and is ultimately wholly owned by Apotex Holdings, Inc. None of
`
`Apotex Inc., Apotex Corp., Apotex Pharmaceuticals Holdings Inc., and Apotex
`
`Holdings, Inc. are publicly traded companies.
`
`According to U.S. Patent Office (“PTO”) records, the assignee of the ’221
`
`patent is OSI Pharmaceuticals, Inc. (Melville, NY) (“OSI” or “Patent Owner”).
`
`II. Notice of Related Matters (37 C.F.R. § 42.8(b)(2))
`The ’221 patent is presently at issue in the following patent infringement
`
`
`
`lawsuits:
`
`LEGAL\31501518\1
`
`2
`
`
`
`IPR2016-01284
`U.S. Patent No. 6,900,221
`PETITIONERS’ UPDATED MANDATORY NOTICE
`
`- OSI Pharmaceuticals, LLC and Genentech, Inc. v. Apotex Inc. and
`
`Apotex Corp., Civil Action No. 1:15-cv-00772-SLR (D. Del); and
`
`- Pfizer Inc., OSI Pharmaceuticals, LLC and Genentech, Inc. v.
`
`Breckenridge Pharmaceutical, Inc. and Natco Pharma Ltd., Civil Action
`
`No. 1:15-cv-01063-SLR (D. Del.).
`
`a. Identification of Counsel (37 C.F.R. § 42.8(b)(3))
`Lead Counsel
`Back-Up Counsel
`Aaron S. Lukas, Ph.D.
`William Blake Coblentz
`(Reg. No. 59,443)
`(Reg. No. 57,104)
`COZEN O’CONNOR
`COZEN O’CONNOR
`1200 19th Street, N.W.
`1200 19th Street, N.W.
`Washington, D.C. 20036
`Washington, D.C. 20036
`Telephone No.: 202-912-4823
`Telephone No.: 202-912-4837
`Fax. No.: 202-861-1905
`Fax. No.: 202-861-1905
`Email: alukas@cozen.com
`Email: wcoblentz@cozen.com
`
`Kerry B. McTigue
`(Pro Hac Vice Admission pending)
`COZEN O’CONNOR
`1200 19th Street, N.W.
`Washington, D.C. 20036
`Telephone No.: 202-912-4810
`Fax. No.: 202-861-1905
`Email: kmctigue@cozen.com
`
`
`
`
`
`
`
`
`LEGAL\31501518\1
`
`3
`
`
`
`IPR2016-01284
`U.S. Patent No. 6,900,221
`PETITIONERS’ UPDATED MANDATORY NOTICE
`b. Service Information (37 C.F.R. § 42.8(b)(4))
`Please direct all correspondence to lead counsel and back-up counsel at the
`
`
`
`
`
`contact information above. Petitioners consent to service by electronic mail at the
`
`email addresses set forth above.
`
`
`
`
`
`
`
`
`
`Dated: July 6, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`LEGAL\31501518\1
`
`Respectfully Submitted,
`
`/W. Blake Coblentz/
`W. Blake Coblentz
`Reg. No. 57,104
`Counsel for Petitioners
`
`COZEN O’CONNOR PC
`1200 Nineteenth St. N.W.
`Washington, D.C. 20036
`202-912-4837
`wcoblentz@cozen.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
`
`
`IPR2016-01284
`U.S. Patent No. 6,900,221
`PETITIONERS’ UPDATED MANDATORY NOTICE
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that, on July 6, 2017, I caused a true and correct copy of the
`
`foregoing materials:
`
`- PETITIONERS’ UPDATED MANDATORY NOTICE
`to be served via electronic mail on the following attorneys of record:
`
`Emily Whelan
`Jonathan B. Roses
`Kevin M. Yurkerwich
`Amy K. Wigmore
`Wilmer Cutler Pickering Hale and Dorr LLP
`60 State St.
`Boston, MA, 02109
`617-526-6000
`Emily.Whelan@wilmerhale.com
`Jonathan.Roses@wilmerhale.com
`Kevin.Yurkerwich@wilmerhale.com
`Amy.Wigmore@wilmerhale.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`By:
`
`
`
`
`/W. Blake Coblentz/
`W. Blake Coblentz
`Reg. No. 57,104
`Counsel for Petitioners
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`COZEN O’CONNOR PC
`1200 Nineteenth St. NW
`Washington, D.C. 20036
`202-912-4837
`wcoblentz@cozen.com
`
`LEGAL\31501518\1
`
`5
`
`